Ernexa Therapeutics (ERNAW) Other Operating Expenses (2010 - 2026)

Ernexa Therapeutics (ERNAW) has 14 years of Other Operating Expenses data on file, last reported at $2.0 million in Q1 2026.

• Quarterly Other Operating Expenses changed N/A year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 229.7% YoY) and the FY2024 annual result came in at -$1.6 million, down 442.61% from the prior year.
• Other Operating Expenses climbed to $2.0 million in Q1 2026, from -$1.6 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $2.0 million in Q1 2026 to a low of -$1.6 million in Q3 2024.
• A 3-year average of $309333.3 and a median of $460000.0 in 2023 frame the typical range for Other Operating Expenses.